Insulin-Like growth factor-I mRNA and peptide in the human anterior pituitary

Journal of Neuroendocrinology

Volumn 19, Issue 5, 2007, Pages 335-341

  Jevdjovic, T ^a   Bernays, R L ^b   Eppler, Elisabeth ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

ACTH; Adenohypophysis; Coexistence; GH; Human; IGF I

Indexed keywords

CORTICOTROPIN; FOLLITROPIN; GROWTH HORMONE; LUTEINIZING HORMONE; MESSENGER RNA; SOMATOMEDIN C;

ADENOHYPOPHYSIS; ADULT; ARTICLE; AUTOCRINE EFFECT; CARCINOGENESIS; CASE REPORT; CELL ULTRASTRUCTURE; CONTROLLED STUDY; FEMALE; GONADOTROPIN SECRETING CELL; HORMONE RELEASE; HORMONE SYNTHESIS; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOPHYSIS ADENOMA; IMMUNOCOMPETENT CELL; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; IN SITU HYBRIDIZATION; LIVER; MALE; MEDICAL RESEARCH; NUCLEOTIDE SEQUENCE; PARACRINE SIGNALING; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REPRODUCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA SEQUENCE; SECRETORY GRANULE; TUMOR GROWTH;

ADRENOCORTICOTROPIC HORMONE; ADULT; FEMALE; GROWTH HORMONE; HUMANS; IMMUNOHISTOCHEMISTRY; INSULIN-LIKE GROWTH FACTOR I; LIVER; MALE; MIDDLE AGED; PITUITARY GLAND, ANTERIOR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TISSUE DISTRIBUTION;

EID: 34147147042     PISSN: 09538194     EISSN: 13652826     Source Type: Journal    
DOI: 10.1111/j.1365-2826.2007.01539.x     Document Type: Article

References (61)

1. Farrell WE, Clayton RN. Molecular genetics of pituitary tumours. TEM 1998; 9: 20-27.
2. Melmed S. Mechanisms of pituitary tumorigenesis: The plastic pituitary. J Clin Invest 2003; 112: 1603-1618.
3. Alexander JM, Biller BM, Bikkal H, Zervas NT, Arnol A, Kibanski A. Clinically non-functioning tumours are monoclonal in origin. J Clin Invest 1990; 86: 336-340.
4. Herman V, Fagin J, Gonsky R, Kovacs K, Melmed S. Clonal origin of pituitary adenomas. J Clin Endocrinol Metabol 1990; 71: 1427-1433.
5. Nolan LA, Lunness HR, Lightman SL, Levy A. The effects of age and spontaneous adenoma formation on trophic activity in the rat pituitary gland: A comparison with trophic activity in the human pituitary and in human pituitary adenomas. J Neuroendocrinol 1999; 11: 393-401.
6. Savage JJ, Yaden BC, Kiratipranon P, Rhodes SJ. Transcriptional control during mammalian anterior pituitary development. Gene 2003; 319: 1-19.
7. Renner U, Mojto J, Arzt E, Lange M, Stalla J, Muller OA, Stalla GK. Secretion of polypeptide growth factors by human nonfunctioning pituitary adenoma cells in culture. Neuroendocrinology 1993; 57: 825-834.
8. Jones JI, Clemmons DR. Insulin-like growth factors and their binding proteins: Biological actions. Endocr Rev 1995; 16: 3-34.
9. Reinecke M. Insulin and the insulin-like growth factors. In: Reinecke M, Zaccone G, Kapoor BG, eds. Fish Endocrinology, Vol. 1. Enfield, NH: Science Publishers, 2006: 3-13.
10. Wallenius K, Sjogren K, Peng XD, Park S, Wallenius V, Liu JL, Umaerus M, Wennbo H, Isaksson O, Frohman L, Kineman R, Ohlsson C, Jansson JO. Liver-derived IGF-I regulates GH secretion at the pituitary level in mice. Endocrinology 2001; 142: 4762-4770.
11. Cohen P. Overview of the IGF-I system. Horm Res 2006; 65 (Suppl.): 3-8.
12. Reinecke M, Schmid AC, Heyberger-Meyer B, Hunziker EB, Zapf J. Effect of growth hormone and insulin-like growth factor I (IGF-I) on the expression of IGF-I messenger ribonucleic acid and peptide in rat tibial growth plate and articular chondrocytes in vivo. Endocrinology 2000; 141: 2847-2453.
13. Maake C, Reinecke M. Immunohistochemical localization of insulin-like growth factor 1 and 2 in the endocrine pancreas of rat, dog, and man, and their coexistence with classical islet hormones. Cell Tissue Res 1993; 273: 249-259.
14. Jevdjovic T, Maake C, Zwimpfer C, Krey G, Eppler E, Zapf J, Reinecke M. The effect of hypophysectomy on pancreatic islet hormone and insulin-like growth factor I content and mRNA expression in the rat. Histochem Cell Biol 2005; 123: 179-188.
15. Chatelain PG, Avallet MO, Nicolino M, Lejeune H, Clark A, Chuzel F, Penhoat A, Saez JM. Insulin-like growth factor I actions on steroidogenesis. Acta Paediatr 1994; 399 (Suppl.): 176-177.
16. Mason HD, Cwyfan-Hughes SC, Heinrich G, Franks S, Holly JM. Insulin-like growth factor (IGF) I and II, IGF-binding proteins, and IGF-binding protein proteases are produced by theca and stroma of normal and polycystic human ovaries. J Clin Endocrinol Metab 1996; 81: 276-284.
17. Aberg ND, Brywe KG, Isgaard J. Aspects of growth hormone and insulin-like growth factor-I related to neuroprotection, regeneration, and functional plasticity in the adult brain. Scientific World J 2006; 6: 53-80.
18. Bach MA, Bondy CA. Anatomy of the pituitary insulin-like growth factor system. Endocrinology 1992; 131: 2588-2594.
19. Olchovsky D, Song J, Gelato MC, Sherwood J, Spatola E, Bruno JF, Berelowitz M. Pituitary and hypothalalmic insulin-like growth factor-I (IGF-I) and IGF-I receptor expression in food-deprived rats. Mol Cell Endocrinol 1993; 93: 193-198.
20. González-Parra S, Argente J, Chowen JA, van Kleffens M, van Neck JW, Lindenbeigh-Kortleve DJ, Drop SL. Gene expression of the insulin-like growth factor system during postnatal development of the rat pituitary gland. J Neuroendocrinol 2001; 13: 86-93.
21. Eppler E, Jevdjovic T, Maake C, Reinecke M. Insulin-like growth factor I (IGF-I) and its receptor IGF-1R in the rat anterior pituitary. Eur J Neurosci 2007; 25: 191-200.
22. Iida K, Del Rincon JP, Kim DS, Itoh E, Nass R, Coschigano KT, Kopchick JJ, Thorner MO. Tissue-specific regulation of growth hormone (GH) receptor and insulin-like growth factor-I gene expression in the pituitary and liver of GH-deficient (lit/lit) mice and transgenic mice that overexpress bovine GH (bGH) or a bGH antagonist. Endocrinology 2004; 145: 1564-1570.
23. Lu F, Yang K, Han VK, Challis JR. Expression, distribution, regulation and function of IGFs in the ovine fetal pituitary. J Mol Endocrinol 1995; 14: 323-336.
24. Adam CL, Gadd TS, Findlay PA, Wathes DC. IGF-I stimulation of luteinizing hormone secretion, IGF-binding proteins (IGFBPs) and expression of mRNAs for IGFs, IGF receptors and IGFBPs in the ovine pituitary gland. J Endocrinol 2000; 166: 247-254.
25. Ren P, Schelthauer BW, Halper J. Immunohistological localization of TGFalpha, RGF, IGF-I, and TGFbeta in the normal human pituitary gland. Endocr Pathol 1994; 5: 40-48.
26. Alberti VN, Takita LC, De Mesquita IS, Percario S, Maciel RMB. Immunohistochemical demonstration of insulin-like growth factor I (IGF-I) in normal and pathological human pituitary glands. Path Res Pract 1991; 187: S41-S42.
27. Oomizu S, Takeuchi S, Takahashi S. Stimulatory effect of insulin-like growth factor I on proliferation of mouse pituitary cells in serum-free culture. J Endocrinol 1998; 157: 53-62.
28. Melmed S, Yamashita S, Yamasaki H, Fagin J, Namba H, Yamamoto H, Weber M, Morita S, Webster J, Prager D. IGF-I receptor signalling: Lessons from the somatotroph. Rec Progr Horm Res 1996; 51: 189-215.
29. Honda J, Manabe Y, Matsumura R, Takeuchi S, Takahashi S. IGF-I regulates pro-opiomelanocortin and GH gene expression in the mouse pituitary gland. J Endocrinol 2003; 178: 71-82.
30. LeRoith D, Roberts CT Jr. The insulin-like growth factor system and cancer. Cancer Lett 2003; 195: 127-137.
31. Zapf J, Gosteli-Peter M, Weckbecker G, Hunziker EB, Reinecke M. The somatostatin analog octreotide inhibits GH-stimulated, but not IGF-I-stimulated, bone growth in hypophysectomized rats. Endocrinology 2002; 143: 2944-2952.
32. David I, Bosshard R, Kloas W, Reinecke M. Insulin-like growth factor I (IGF-I) in the pituitary of Xenopus laevis: Immunocytochemical and autoradiographic indication for a paracrine action and co-release with prolactin. J Neuroendocrinol 2000; 12: 415-420.
33. Eppler E, Zapf J, Bailer N, Falkmer UG, Falkmer S, Reinecke M. IGF-I in human breast cancer: Low differentiation stage is associated with decreased IGF-I content. Eur J Endocrinol 2002; 146: 813-821.
34. Berishvili G, D'Cotta H, Baroiller JF, Segner H, Reinecke M. Differential expression of IGF-I mRNA and peptide in the male and female gonad during early development of a bony fish, the tilapia Oreochromis niloticus. Gen Comp Endocrinol 2006; 146: 204-210.
35. Eppler E, Shved N, Moret O, Reinecke M. IGF-I is distinctly located in the bony fish pituitary as revealed for Oreochromis niloticus, the Nile tilapia, using real-time RT-PCR, in situ hybridisation and immunohistochemistry. Gen Comp Endocrinol 2007; 150: 87-95.
36. White A, Gray C, Ratcliffe JG. Characterisation of monoclonal antibodies to adrenocorticotrophin. J Immunol Meth 1985; 79: 173-331.
37. White A, Smith H, Hoadley M, Dobson SH, Ratcliffe JG. Clinical evaluation of a two-site immunoradiometric assay for adrenocorticotrophin in unextracted human plasma using monoclonal antibodies. Clin Endocrinol (Oxford) 1987; 26: 41-51.
38. Rhodes A, Chan KK. The neuropathology module. Immunocytochemistry 2002; 2: 31-35.
39. Berger P. Molecular morphology of placental and pituitary hormones: epitope mapping with monoclonal antibodies. Wien Klin Wochenschr 1985; 97: 573-581.
40. Schwarz S, Berger P, Wick G. The antigenic surface of human chorionic gonadotropin as mapped by murine monoclonal antibodies. Endocrinology 1986; 118: 189-197.
41. Madersbacher S, Shu-Chen T, Schwarz S, Dirnhofer S, Wick G, Berger P. Time-resolved immunofluorometry and other frequently used immunoassay types for follicle-stimulating hormone compared by using identical monoclonal antibodies. Clin Chem 1993; 39: 1435-1439.
42. Portela-Gomes GM, Lukinius A, Grimelius L. Synaptic vesicle protein 2, a new neuroendocrine cell marker. Am J Pathol 2000; 157: 1299-1309.
43. Boon K, Edwards JB, Siu I-M, Olschner D, Eberhart CG, Marra MA, Strausberg RL, Riggins GJ. Comparison of medulloblastoma and normal neural transcriptomes identifies a restricted set of activated genes. Oncogene 2003; 22: 7687-7694.
44. Kline JB, Clevenger CV. Identification and characterization of the prolactin-binding protein in human serum and milk. J Biol Chem 2001; 276: 24760-24766.
45. Antonson P, Schuster GU, Wang L, Rozell B, Holter E, Flodby E, Flodby P, Treuter E, Holmgren L, Gustafsson J-Å. Inactivation of the nuclear receptor coactivator RAP250 in mice results in placental vascular dysfunction. Mol Cell Biol 2003; 23: 1260-1268.
46. Melamed P, Gur G, Rosenfeld H, Eilzur A, Yaron Z. Possible interactions between gonadotrophs and somatotrophs in the pituitary of the tilapia: apparent roles for insulin-like growth factor I and estradiol. Endocrinology 1999; 140: 1183-1191.
47. Schmidt WK, Moore HP. Synthesis and targeting of insulin-like growth factor-I to the hormone storage granules in an endocrine cell line. J Biol Chem 1994; 269: 27115-27124.
48. Fagin JA, Pixley S, Slanina S, Ong J, Melmed S. Insulin-like growth factor I gene expression in GH3 rat pituitary cells: Messenger ribonucleic acid content, immunocytochemistry, and secretion. Endocrinology 1987; 120: 2037-2043.
49. Fagin JA, Fernandez-Mejia C, Melmed S. Pituitary insulin-like growth factor-I gene expression: Regulation by triiodothyronine and growth hormone. Endocrinology 1989; 125: 2385-2391.
50. Olchovsky D, Bruno JF, Gelato MC, Song J, Berelowitz M. Pituitary insulin-like growth factor-I content and gene expression in the streptozotocin-diabetic rat: Evidence for tissue-specific regulation. Endocrinology 1991; 128: 923-928.
51. Castillo AI, Aranda A. Differential regulation of pituitary-specific gene expression by insulin-like growth factor 1 in rat pituitary GH4C1 and GH3 cells. Endocrinology 1997; 138: 5442-5451.
52. Yamasaki H, Prager D, Gebremedin S, Moise L, Melmed S. Binding and action of insulin-like growth factor I in pituitary tumor cells. Endocrinology 1991; 128: 857-862.
53. Soldani R, Cagnacci A, Yen SS. Insulin, insulin-like growth factor I (IGF-I) and IGF-II enhance basal and gonadotrophin-releasing hormone-stimulated luteinizing hormone release from rat anterior pituitary cells in vitro. Eur J Endocrinol 1994; 131: 641-645.
54. Dekeyser J, Wilczak N, Debacker JP, Herroelen L, Vauquelin G. Insulin-like growth-factor-I receptors in human brain and pituitary gland, an autoradiographic study. Synapse 1994; 17: 196-202.
55. Kola B, Korbonits M, Diaz-Cano S, Kaltsas G, Morris DG, Jordan S, Metherell L, Powell M, Czirjak S, Arnaldi G, Bustin S, Boscaro M, Mantero F, Grossman AB. Reduced expression of the growth hormone and type 1 insulin-like growth factor receptors in human somatotroph tumours and an analysis of possible mutations of the growth hormone receptor. Clin Endocrinol (Oxford) 2003; 59: 328-338.
56. Rosenfeld RG, Ceda G, Wilson DM, Dollar LA, Hoffman AR. Characterization of high affinity receptors for insulin-like growth factors I and II on rat anterior pituitary cells. Endocrinology 1984; 114: 1571-1575.
57. Yamamoto H, Prager D, Yamasaki H, Melmed S. Rat pituitary GC insulin-like growth factor-I receptor regulation. Endocrinology 1993; 133: 1420-1425.
58. Hazlerigg DG, Thompson M, Hastings MH, Morgan PJ. Regulation of mitogen-activated protein kinase in the pars tuberalis of the ovine pituitary: Interactions between melatonin, insulin-like growth factor-1, and forskolin. Endocrinology 1996; 137: 210-218.
59. Honda J, Takeuchi S, Fukamachi H, Takahashi S. Insulin-like growth factor-I and its receptor in mouse pituitary glands. Zool Sci 1998; 4: 573-579.
60. Reinecke M, Collet C. The phylogeny of the insulin-like growth factors. Int Rev Cytol 1998; 183: 1-94.
61. Jenkins PJ, Bustin SA. Evidence for a link between IGF-I and cancer. Eur J Endocrinol 2004; 151 (Suppl. 1): S17-S22.